AZD-7594

  • Purchase Qty: 100 500 1000
  • Unit: mg(s) mg(s) mg(s)
  • Fob Unit Price: US $500 US $800 US $1200
  • Payment Terms:T/T , PayPal
  • Favorite
Shanghai Caerulum Pharma Discovery

Business Type:Manufacturer

Country/Region:China

Ddu Verified

HOT Rank

8/10

Product Information

  • CAS:1196509-60-0
  • Active Ingredients:3-(5-((1R,2S)-2-(2,2-difluoropropanamido)-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)propoxy)-1H-indazol-1-yl)-N-(tetrahydrofuran-3-yl)benzamide
  • Chemical Formula:C32H32F2N4O6
  • Molecular Weight:606.6268
  • Assay:min 98%
  • Pharmacopeia:CP
  • Shelf Life:2 years
  • Storage:Sealed
  • Place of Origin:China

Description

AZD-7594, also known as AZ13189620, is an inhaled selective glucocorticoid receptor (GCCR) modulator. AZD-7594 is in phase II clinical trials by AstraZeneca for the treatment of mild to moderate asthma. It is also in phase I clinical trials for the treatment of chronic obstructive pulmonary disorder (COPD).


Shanghai Caerulum Pharma Discovery is the manufacturer of APIs and intermediates of some of the latest compounds in the market. Our focus is on cancer, diabetes and other therapeutic areas.

 

Shanghai Caerulum Pharma Discovery (CPD) offers high quality and reliable chemical products and integrated biological services including:

1)       Best offer for existing APIs and intermediates

2)       Custom-synthesis APIs and intermediates

3)       DMPK

4)       Biological screening

5)       Drug Safety Evaluation



You Might Also Like
Change a group
Inquiry Cart(0)